2019
DOI: 10.3918/jsicm.26_405
|View full text |Cite
|
Sign up to set email alerts
|

A case of intoxication relapse of pilsicainide after the transient recovery using hemoperfusion from the toxicity with electrocardiogram (ECG) abnormalities

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 4 publications
0
1
0
Order By: Relevance
“…There are no antidotes or antagonists for pilsicainide, and its removal rate is reported to be as low as 37% on HD, 25% on hemofiltration dialysis, and 45% on plasma exchange. Because a slight decrease in the serum concentration of pilsicainide has been reported to improve symptoms 6) and repeated polymorphic VT occurred in our case, we intervened with HD to try to immediately decrease the serum concentration. Magnesium sulfate was reported 7) as another treatment option.…”
Section: Discussionmentioning
confidence: 98%
“…There are no antidotes or antagonists for pilsicainide, and its removal rate is reported to be as low as 37% on HD, 25% on hemofiltration dialysis, and 45% on plasma exchange. Because a slight decrease in the serum concentration of pilsicainide has been reported to improve symptoms 6) and repeated polymorphic VT occurred in our case, we intervened with HD to try to immediately decrease the serum concentration. Magnesium sulfate was reported 7) as another treatment option.…”
Section: Discussionmentioning
confidence: 98%